EE466 The Potential Public Health and Economic Benefit of an mRNA-Based Respiratory Syncytial Virus Vaccine Among Adults ≥60 Years in the United States
Abstract
Authors
K Fust P Ghaswalla K Joshi Van de Velde N M Kohli
K Fust P Ghaswalla K Joshi Van de Velde N M Kohli
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now